INTRODUCTION
============

Proper wiring of the nervous system requires that axonal growth cones respond to a variety of extracellular guidance cues to find their correct targets ([@B49]). Semaphorin 3a (Sema3a) is one of many diffusible developmental cues and has been shown to repel axons of responsive neuronal populations ([@B82]). Addition of Sema3a to cortical neuron cultures causes rapid filopodial retraction (within 5 min) and ultimately collapse of many axonal growth cones ([@B23]). Binding of Sema3a to its receptor neuropilin1 and coreceptor PlexinA4 leads to downstream activation of the neuronal serine/threonine kinase cyclin-dependent kinase 5 (cdk5) ([@B77]; [@B15]; [@B69]). Cdk5 is critical for early neuronal development as a regulator of cytoskeleton, trafficking, and membrane dynamics and thus cell morphology ([@B45]). Sema3a-­activated cdk5 phosphorylates multiple substrates to affect the assembly and dynamics of both the actin and microtubule cytoskeleton and of adhesion components, which results in filopodial retraction and growth cone collapse in vitro ([@B77]; [@B65]). Not all cortical neurons are repelled by Sema3a, and the molecular mechanisms for this differential responsiveness are under active investigation ([@B61]; [@B11]; [@B42]; [@B105]).

Intermediate filaments are generally thought to provide structure and stability to a cell. In adult neurons, neuronal intermediate filaments, the neurofilaments, play such a structural role to maintain axon caliber ([@B51]). In addition to the classic neurofilaments, other intermediate filament subunits are expressed during neural development. Vimentin and nestin are both strongly expressed in neural progenitor cells (NPCs), so much so that nestin expression is widely used as a marker for NPCs. α-Internexin (INA) and neurofilament protein expression, on the other hand, are up-regulated only after neurons differentiate. Neurofilaments, INA, and vimentin (all expressed in CNS neurons) have also been shown to play additional but poorly understood roles in early neuritogenesis ([@B79]; [@B78]; [@B90]; [@B53]). The function of nestin in neurons has not been investigated, because nestin is not thought to be expressed in neurons.

Little is known about nestin's function, even in NPCs, where it is highly expressed ([@B76]), but it appears to offer some protection from cellular stress. In addition, nestin is often expressed in cancer cells and has well-documented effects on cancer cell migration and invasion by influencing cytoskeletal dynamics and kinase activity ([@B41]; [@B102]; [@B55]; [@B98]). Nestin's developmental function is best understood in muscle, where it acts as a scaffold and regulator for cdk5 at the neuromuscular junction (NMJ). At the NMJ, nestin deletion phenocopies cdk5 deletion ([@B56]), and nestin is required for the acetylcholine agonist carbachol-induced cdk5 activity ([@B62]; [@B67]; [@B100]). The binding site for the p35/cdk5 complex has been mapped to the unique long C-terminal tail of nestin ([@B75], [@B76]), which is much larger than conventional intermediate filaments (57 kDa vimentin vs. ∼300 kDa nestin).

In this work, we show for the first time that nestin has a function in postmitotic newborn cortical neurons. We first characterized the patterns of endogenous nestin expression. As expected, we find that nestin is strongly expressed in NPCs. Unexpectedly, nestin protein can be detected during early, but critical, periods of axon formation and is subsequently lost. Second, we found that depletion of nestin affects the growth cone morphology of immature cortical neurons. Last, we discovered that nestin depletion from cultured neurons decreases their sensitivity to Sema3a in a roscovitine-­dependent manner. On the basis of our data, we propose that nestin acts as a "gain control" modulator of Sema3a growth cone signaling during early neuronal differentiation. Because neurons can encounter the same cue at different developmental stages, but respond differently ([@B49]), nestin's modulation of Sema3a responsiveness might be one mechanism to temporally and spatially regulate differential axon guidance decisions in the cortex.

RESULTS
=======

Nestin protein expression persists in immature primary cortical neurons in culture
----------------------------------------------------------------------------------

Nestin protein is expressed at high levels in cortical radial glia/neural progenitor cells (NPCs) ([@B54]). In contrast, doublecortin (DCX) and βIII-tubulin expression is low or absent in NPCs but up-regulated in postmitotic neurons ([@B31]). Nestin and DCX/βIII-tubulin are thus routinely used as markers to distinguish these mutually exclusive cell types. E16 mouse dissociated cortical neurons were cultured for 1 d in vitro (DIV) and immunostained against nestin and DCX. To our surprise, many DCX-positive cells were also positive for nestin ([Figure 1](#F1){ref-type="fig"}A). These DCX/nestin--double positive cells had the morphology of stage 3 immature neurons (using Banker staging; see *Materials and Methods*; [@B27]; [Figure 1](#F1){ref-type="fig"}A) and were positive for neuronal-specific βIII-tubulin (see [Figure 2](#F2){ref-type="fig"}D), indicating that they had differentiated into neurons. In addition, GFAP (a marker of astrocytes) was not detected at this early stage of development (unpublished data), in agreement with studies that show that gliogenesis, the formation of astrocytes or oligodendrocytes, does not begin until E17/18 or postnatally, respectively ([@B60]). We note that cells lacking neurites were generally nestin-positive and likely correspond to NPCs and some early stage 1 neurons (see [Figure 1](#F1){ref-type="fig"}D). Cells with short processes that might correspond to stage 2 neurons or to nonneuronal cell types had variable nestin expression.

![Nestin protein expression persists in immature primary cortical neurons in culture. (A). Nestin expression in cultures derived from E16 mouse cortex grown for 1 d (1DIV). Doublecortin (DCX) immunostaining and a stage 3 morphology were used to identify neurons. Nestin is enriched near the axonal growth cone (pink arrowheads), but largely absent from growth cones of minor dendrites (white arrows) using both mouse and chicken anti-nestin antibodies. White arrowheads indicate short nestin intermediate filament segments found along the axon shaft. Bottom panel is enlarged inset of growth cone, rotated, from within the white box. Growth cone outline drown from the phalloidin stain shown in the panels with phalloidin and in the enlargement. (B) Validation of nestin antibody staining on stage 3 neurons with mouse and goat anti-nestin antibodies with immunizing peptide antibody blocking. Both antibodies again show a distal axon enrichment of nestin (pink arrowheads), while the dendrites again are not labeled (white arrows). Preincubation of the goat anti-nestin antibody with the immunizing peptide abolishes all staining, but staining in the distal axons is still detectable with the mouse anti-nestin antibody, which was raised against a different epitope. Shown are E16 mouse cortical neurons 1DIV. Bottom panel is enlarged inset of growth cone from within the white box. Growth cone outline drawn from the phalloidin stain shown in the panels with phalloidin and in the enlargement. (C) Nestin siRNA results in loss of immunostaining, validating that the axonal growth cone staining is due to nestin protein. GFP was cotransfected as a transfection indicator. After 36 h in culture, cells were fixed and immunostained for nestin and DCX. The number of GFP positive cells positive for nestin in the axon as a fraction of the number of cells counted was quantified. (D) Nestin is colocalized with other intermediate filaments in the same assembly group (vimentin and Neurofilament-Medium NF-M) in the distal axons (pink arrowheads) of E16 mouse cortical neurons 1DIV. NF-M expression was low in immature cortical neurons cultured for only 1DIV. High magnification of the boxed region and line scans reveal that nestin and NF-M appear to decorate the same filament structure in partially colocalizing subdomains, as expected for nestin-containing intermediate filaments. Pink arrowheads indicate nestin-positive axonal intermediate filament heteropolymers.](mbc-30-1214-g001){#F1}

![Nestin-expressing neurons are observed in multiple rodent and human culture models. (A) Mouse neurosphere NPC cultures: nestin expression was assessed in differentiating dissociated neural progenitor cells (mouse NPC) after 4 d of neuronal differentiation. DCX-positive neurons frequently stain positive for nestin (yellow asterisks), especially in axon tips (pink arrowheads). An example of an axon positive for DCX but not nestin is marked with a series of white arrowheads along the length of the long and thin axon, and a large white arrowhead indicating the growth cone. Nestin--single positive cells are marked with pink asterisks. One example of a double-positive cell is shown in the middle panels to highlight its neuronal morphology and tip-enriched nestin staining (pink arrowhead). The proportion of cells positive for only nestin (red bar) or only DCX (green bar) or double-positive for DCX and nestin (yellow bar) was quantified for NPCs cultured under differentiation conditions from 1 or 4 d. Yellow dotted lines highlight the expanding double positive population (yellow bar). Three hundred twenty-three cells were counted at 1 DIV, and 219 cells at 4 DIV. (B) Human IPSC--derived neuronal cultures: nestin is expressed in human (IPSC) differentiating neurons derived from NPCs in dissociated cultures under differentiating conditions from 1, 4, and 6 d. The distribution of nestin is similar to that in the mouse NPC--derived neurons described above. Percent colocalization with the neuronal-specific βIII tubulin was quantified. A close-up of a nestin-positive axon tip in the boxed region is shown in the panels below the respective images. *n* = 14 (day 1), 10 (day 4), and 14 (day 6--8). (Statistics: Mann--Whitney *t* test). (C) Mouse primary neuron cortical neuron cultures: percentage of nestin-positive neurons decreases rapidly with time in culture (30--60 stage 3 neurons were counted per time point for 3--5 experiments, as shown as the *n*). Cortical neuron cultures were prepared from E16 mice embryos and culture times are indicated. (D) Mouse primary explants: axonal nestin expression is progressively lost between 36 and 72 h in culture. Significant axonal nestin immunostaining is no longer detected by 72 h. E16 mouse cortex was explanted by incomplete dissociation and cultured. Axon fascicles emerging from the explant are shown. Arrowheads point to axon tips.](mbc-30-1214-g002){#F2}

Because nestin is considered a marker of NPCs, we performed a series of rigorous controls to validate the observed staining. We obtained two additional nestin antibodies (raised in chickens \[Chk\] or goats \[Gt\]), all against different epitopes in the C-terminal region of nestin. Both antibodies produced immunostaining patterns similar to those for the mouse anti-nestin antibody ([Figure 1](#F1){ref-type="fig"}, A and B). A blocking peptide was available for the goat anti-nestin antibody that allowed testing the specificity of the observed axonal nestin staining. Preincubation of the goat anti-nestin antibody with the immunizing peptide before labeling specifically reduced immunostaining with the goat antibody, but nestin was still detected in distal axons with the mouse anti-nestin antibody in the same cell ([Figure 1](#F1){ref-type="fig"}B). Both of these antibodies appear to be highly specific to nestin, since they detected single bands (∼300 kDa) by immunoblot (consistent with the expected size of nestin) in DIV1 E16 cortical mouse neuron lysate (Supplemental Figure S1B).

As an additional validation of antibody specificity, we performed nestin knockdowns with either control nontargeting small interfering RNA (siRNA) (siCon) or a nestin-specific pool of 4 siRNAs (siNes-pool) using Amaxa nucleofection before plating dissociated neurons. GFP was coelectroporated to visualize transfected cells ([Figure 1](#F1){ref-type="fig"}C). Cultures were fixed after 36 h and stained for nestin. The intensity of axonal nestin was then quantified. At 36 h, ∼1/3 of GFP-positive stage 3 neurons stained positive for nestin after siCon electroporation, similarly to untransfected cells (see [Figure 2](#F2){ref-type="fig"}C), whereas nestin staining was significantly reduced and essentially undetectable in GFP-positive cells electroporated with siNes-pool ([Figure 1](#F1){ref-type="fig"}C). The specificity of the three nestin antibodies was also assessed by Western blot after siRNA knockdown in neurons (Supplemental Figure S1A). Electroporation is not very efficient in neurons, and the knockdowns were not complete after 36 h, but decreased nestin levels were found after siNes-pool nucleofection for all three antibodies, confirming that the antibodies were specific for nestin. When mouse nestin-myc was transfected into HEK293 cells together with either siCon or siNes-pool siRNA, a near complete loss of nestin signal was observed in the siNes pool--treated condition, while the related intermediate filament vimentin was not affected (Supplemental Figure S1A'). We conclude that nestin protein is indeed expressed in immature neurons in culture. Close reading of the literature revealed that nestin protein has been detected in neurons in humans and mice, both in early differentiating neurons ([@B13]; [@B59], [@B58]; [@B99]; [@B91]; [@B18]), and in subpopulations of adult neurons ([@B33]; [@B22]; [@B36]; [@B34]; [@B57]). Recent advances in single-cell Western blotting have revealed persistent nestin expression in βIII tubulin positive differentiated neural stem cells ([@B40]).

Despite the evidence that nestin protein expression is not exclusive to neural stem cells, nestin continues to be used as a specific neural--stem cell marker. We thus performed a side-by-side comparison (Supplemental Figure S1C) of nestin staining in cultures counterstained with the NPC marker Sox2 and the neuronal marker DCX to compare the relative levels of nestin protein. This comparison within a single imaging field demonstrates that the nestin protein immunofluorescence level seen in axons (high DCX, but low Sox2 expression) was many times lower than the nestin expression in an NPC cell body (high Sox2, but low DCX expression). High levels of anti-nestin antibody staining were thus confirmed to be a reliable NPC marker when used as a tool to label NPCs and are clearly distinguishable from the lower axonal levels of nestin.

Nestin is present in filaments in distal axons and growth cones
---------------------------------------------------------------

Having validated the nestin antibodies, we next characterized endogenous neuronal nestin distribution. Nestin was not uniformly distributed, but primarily localized to the distal region of the growing axon (pink arrowheads) and was rarely observed in secondary neurites (white arrows; [Figure 1](#F1){ref-type="fig"}A). Variable levels of nestin were often also detected in the cell body. In addition to the distal axon accumulation of nestin, short linear nestin profiles (called squiggles) were often found distributed along the length of the axon (white arrowheads; [Figure 1](#F1){ref-type="fig"}A), which is typical of neurofilaments in young neurons ([@B6]; [@B92]). Nestin is an obligate heteropolymer and requires another cytosolic intermediate filament type to assemble into filaments ([@B83]). If nestin existed as assembled filaments in neurons, it should be as part of filaments composed of other intermediate filament subunits in addition to nestin. Indeed, we found that nestin colocalized with vimentin, neurofilament-medium (NF-M; [Figure 1](#F1){ref-type="fig"}D), α-internexin (INA), and neurofilament-light (NF-L; unpublished data). Neurofilament-heavy (NF-H) was not detected at these early time points, as NF-H is expressed in more mature neurons ([@B6]). A magnification inset and a line scan show that nestin and NF-M occupy subdomains within a heteropolymer, as has been demonstrated with nestin filaments in other cell types ([@B52]).

In addition to assembled nestin-containing filaments (squiggles) along the axon, we also see nestin staining in the growth cone central domain, which extends more peripherally to various degrees. A typical pattern is represented by the growth cone shown enlarged at the bottom of [Figure 1](#F1){ref-type="fig"}A. Nestin staining appears consolidated at this magnification and resolution. Individual filaments cannot easily be discerned. This staining may represent a tight bundle or tangle of short nestin-containing intermediate filaments (squiggles). In more spread growth cones (such as the growth cone shown enlarged at the bottom left of [Figure 1](#F1){ref-type="fig"}B), nestin staining appears clearly filamentous, suggesting that nestin in neurons can exist at least partially as an assembled heteropolymer filament.

Nestin-expressing neurons are observed in multiple rodent and human culture models
----------------------------------------------------------------------------------

Because neurons are not usually thought to express nestin, we looked at other neuronal models to see whether we observed DCX/nestin--double positive neurons in other contexts. When we prepared neuronal cultures from embryonic rat cortex, we also observed DCX/nestin--double positive neurons (unpublished data). Next, we grew mouse NPCs as neurospheres and then differentiated them into neurons in culture in order to determine whether neurons differentiated from NPCs continued to express nestin. Differentiation into neurons takes several days when this protocol is used. One day after neurosphere dissociation and plating, \>95% of cells were nestin-positive, but did not express DCX, consistent with their being NPCs ([Figure 2](#F2){ref-type="fig"}A). The remainder had started to differentiate into neurons and expressed both DCX and nestin. After 4 d of differentiation in dissociated culture, ∼50% of cells had differentiated into neurons (DCX-positive). A large proportion of the DCX-positive neurons also expressed nestin. The DCX/nestin--double positive cells had a morphology similar to that of stage 2 or stage 3 cultured primary neurons, and cells with a stage 3 morphology had nestin localized to the tips of neurites ([Figure 2](#F2){ref-type="fig"}A, inset). Only around 10% of cells had no detectable nestin immunopositivity ([Figure 2](#F2){ref-type="fig"}A) and expressed only DCX, consistent with being more differentiated neurons. Differentiating NPCs after 4 d became too crowded to assess on a cell-by-cell basis.

To test whether human neurons similarly express nestin during early differentiation, we assessed nestin expression in cultures derived from human NPCs derived from induced pluripotent stem cells (IPSCs). At 1 d, nestin expression is high and βIII tubulin expression is low, resulting in low colocalization of nestin and βIII tubulin. After 4 d of differentiation, nestin colocalization with βIII tubulin peaked, and nestin staining was clearly detected at the tips of βIII-tubulin positive axons ([Figure 2](#F2){ref-type="fig"}B), confirming nestin expression in cultures of human neurons also. Colocalization again drops at ∼1 wk due to decreasing nestin expression: however, nestin is still expressed at the tips of some neurites. To assess whether nestin expression occurred in neurons that are differentiating in a more tissuelike context, we also grew human NPCs as large cortical spheroids, often referred to as "minibrains" (Supplemental Figure S2A). Minibrains recapitulate several developmental processes that are also observed during in vivo development. Nestin staining was clearly detected in neurons (identified by βIII-tubulin expression). Nestin staining was most prominent in neuronal processes with lower βIII-tubulin expression (less mature neurons), while cells expressing higher levels of βIII-tubulin (more mature neurons) were mostly negative for nestin. We conclude that nestin is transiently expressed in both human and rodent neurons and can be observed in a model that recapitulates some aspects of human cortical development.

Nestin protein is transiently expressed broadly among cortical neuron cell types but decreases with maturation
--------------------------------------------------------------------------------------------------------------

Typical techniques for culturing primary neurons select for cells that recently completed mitosis or are undergoing migration at the time of dissociation ([@B4]). We thus wondered whether nestin-positive neurons represent a transition state between nestin-positive NPCs and nestin-negative neurons. Alternatively, nestin-positive neurons could be a stable neuronal cell type that maintains nestin expression over longer times in culture. Because cultured cortical neurons maintain cell type fates after dissociation ([@B73]; [@B26]), we used two cell type--specific transcription factors to distinguish cortical-projecting (Satb2-positive) from subcortical-projecting (Ctip2-positive) neurons. Nestin expression in DCX-positive neurons did not correlate with either Ctip2 or Satb2 expression (Supplemental Figure S2B). Similarly, when cultures were prepared from E14, E15, or E16 embryos (representing different cortical layer fates), ∼2/3 of DCX-positive neurons were nestin-positive after 24 h in culture (unpublished data), regardless of embryonic age at dissection. These data suggest that nestin is expressed by immature neurons of all cortical layers.

Because nestin positiveness was not skewed by neuronal cell type, we next assessed whether nestin expression was correlated with time after differentiation. To this end, we utilized an in vitro time course of neurons dissociated from E16 mouse cortex ([Figure 2](#F2){ref-type="fig"}C), since time in culture represents the maturity of the cell. For the first 12--24 h, around two-thirds of stage 3 neurons expressed nestin in the axon. Plating density had no effect on the percentage of neurons that express nestin (unpublished data). Nestin expression dropped steadily after 24 h, with only one-third remaining nestin-positive at 36 h, one-fourth by 48 h, and less than one-tenth by 72 h ([Figure 2](#F2){ref-type="fig"}C). The change in axonal nestin staining is easily appreciated in axon bundles growing from a cortical explant. At 36 h, nestin expression was clearly seen mostly in the distal region of some axons, but was reduced to near-background levels at 72 h ([Figure 2](#F2){ref-type="fig"}D*).* These data demonstrate that nestin is expressed transiently in a substantial subpopulation of differentiating cortical axons and subsequently down-regulated as differentiation proceeds.

Nestin is expressed in subpopulations of developing cortical neurons in vivo
----------------------------------------------------------------------------

We next sought to determine whether there was an in vivo correlate to the axonal nestin expression we observed in cultured neurons. Others have shown that developing cortical neurons in the intermediate zone (IZ) consist of a mixture of axons of variable states of maturation---preexisting axon tracts laid down by earlier pioneer neurons, and later born neurons that initiate axon projections during migration through the IZ ([@B63]). We thus imaged axons in the lower intermediate zone (IZ) of E16 mouse developing cortex, similarly to where nestin mRNA was detected by Dahlstrand *et al.* ([@B20]). In vitro, nestin was not present in all axons and did not fill the whole length of an individual axon. We thus predicted that nestin-positive axons would be detected as a subpopulation of axons in the IZ. We also predicted that axonal nestin would be lower than nestin in NPCs/radial glia.

A low-magnification overview of one hemisphere of the cortex showing vimentin and α-internexin (INA) expression is shown in [Figure 3](#F3){ref-type="fig"}A, along with a schematic to orient the reader. The boxed region in [Figure 3](#F3){ref-type="fig"}A indicates the lateral lower IZ, which is the region in the schematic imaged in the following panels. All panels in [Figure 3](#F3){ref-type="fig"}, B--E, have the radial glia oriented vertically and the axon tracts oriented horizontally. INA is an intermediate filament expressed early in neuronal development, but not expressed in radial glia ([@B44]; [@B30]; [@B20]; [@B6]). As expected, INA is readily detected in axons of the IZ ([Figure 3](#F3){ref-type="fig"}, A and B). Vimentin is expressed in both radial glia and, at a lower level, neurons ([@B17]; [@B8]; [@B96]; [@B88]).

![Nestin is expressed in subpopulations of cortical axons in developing cortex. (A) A low magnification of a coronal cortical section (E16 mouse) is shown for orientation (top) and showing α-internexin localization to the axon-rich intermediate zone. The white box (lateral lower intermediate zone) is the region imaged in the following panels, and is diagramed below (B), illustrating the vertically oriented radial glia and horizontal IZ axon bundles. (C) Superresolution microscopy (STED) of nestin immunostaining reveals bright staining of radial glial fibers (arrowheads) as well as fainter staining of axons (arrows) in mouse E16 cortex*.* Many axons in the axon fascicle do not express nestin, so only a subset of axons in the intermediate zone express nestin at this time point. Arrowheads indicate radial glia and arrows indicate nestin-positive axons. (D) Nestin staining of the lower intermediate zone of E16 mouse cortex using chicken anti-nestin (cyan) and goat anti-nestin (magenta) antibodies. Axon tracts are visualized with α-internexin antibody (white). Nestin staining is found in radial glia fibers (arrowheads) as well as in α-internexin-positive axon tracts (arrows). The goat anti-nestin antibody was preincubated with immunizing peptide on sequential cryosections in the lower panels. All staining with the goat anti-nestin antibody was blocked by peptide preincubation, including the axon tract staining, demonstrating that the axon staining was specific and not background staining. All images correspond to higher magnification of the lower intermediate zone of the lateral E16 mouse cortex (boxed regions in A). Radial glia are oriented vertically (arrowheads) and axon tracts are oriented horizontally (arrows). (E) Identification of nestin-positive axons in mouse cortex. The L1-CAM-positive axons (white) contain mixed populations of both cortical and thalamic projections in this brain region. Nestin (magenta) is specifically expressed in axons originating from the cortex (Tag1-positive, cyan), but not in axons with thalamic origin (calretinin-positive, yellow). Arrowheads indicate radial glia, and arrows indicate nestin-positive and Tag1-positive axons.](mbc-30-1214-g003){#F3}

As expected, nestin staining intensity in the radial glia (arrowheads in [Figure 3](#F3){ref-type="fig"}, C--E) was high, which made evaluation of nestin staining in axon tracts challenging. However, high-resolution confocal microscopy, the use of distinct axonal markers, and sequential imaging of four channels permitted us to resolve and distinguish between the segregated but interwoven cellular processes of radial glial and IZ axons. Staining with chicken and goat anti-nestin antibodies labeled the bright radial glia fibers (INA-negative) oriented vertically (arrowheads; [Figure 3](#F3){ref-type="fig"}D). Similarly to nestin mRNA ([@B20]), INA is present in early cortical axon tracts (arrows), and nestin immunoreactivity was clearly detected in these axon tracts, albeit at lower levels than in radial glia fibers. This staining pattern is similar to what is seen with in vitro axon bundles ([Figure 2](#F2){ref-type="fig"}D). Early defining work had observed low nestin staining on spinal cord axons, but attributed it to background staining by the antibody ([@B38]). To assess the specificity of nestin staining on IZ axons, we repeated the peptide-blocking assay used in [Figure 1](#F1){ref-type="fig"} for the goat anti-nestin antibody on E16 cryosections ([Figure 3](#F3){ref-type="fig"}D). The staining by the goat nestin antibody was completely blocked by preincubation with the immunizing peptide, both on radial glia fibers and on axon tracts, indicating specific staining of nestin on axons in vivo. Both radial glia fibers and axons were still stained with the chicken nestin antibody. In addition, specificity of both the mouse 2q178 antibody and the goat antibody to nestin was assessed by immunoblot of E16 mouse cortex lysate and resulted in clearly labeled single bands that corresponds to the expected size of the nestin protein (Supplemental Figure S1B'). Furthermore, the ∼300-kDa band recognized by the goat nestin antibody could be specifically reduced by preincubation with the immunizing peptide, arguing that the observed staining of IZ axons can be attributed to nestin (Supplemental Figure S1B').

To further characterize the intermediate filament content of the lower IZ axons, costaining for nestin and vimentin was performed (Supplemental Figure S3, A and B). Vimentin was found to have a staining pattern similar to that of nestin, with high levels in radial glia and low levels in axons. The nestin- and vimentin-positive IZ fibers were also positive for the axon marker L1-CAM (Supplemental Figure S3, A and B), confirming their identity as axons. The same axonal nestin staining pattern was seen with the mouse anti-nestin Rat401 monoclonal antibody, the initial antibody used to characterize and define nestin ([@B38]; Supplemental Figure S3B). Thus, multiple pieces of evidence demonstrate that nestin is expressed in axons in the IZ at E16 in mouse cortex.

To better visualize the axonal nestin, we performed STED superresolution microscopy on goat anti-nestin immunostained E16 mouse cortex. The bright nestin-positive radial glia fibers were again the most prominently stained feature, but individual axons with less bright nestin staining could be unambiguously resolved. Nestin is clearly present on a subset of axons of the IZ ([Figure 3](#F3){ref-type="fig"}C*).* In addition to the axons of cortical neurons (Tag-1 positive) of variable maturity, the IZ contains axons of neurons projecting from the thalamus, calretinin-positive thalamocortical neurons ([@B81]). We thus used these markers to further define the nestin expressing subpopulations ([Figure 3](#F3){ref-type="fig"}E): L1-CAM for all axons, Tag-1 for cortical axons, and calretinin for thalamocortical axons. Intriguingly, we observed that a subpopulation of cortical (Tag-1 positive) axons had detectable nestin staining, whereas the calretinin-­positive (thalamocortical) axons lacked nestin staining ([Figure 3](#F3){ref-type="fig"}E). However, we note that this could be due to differences in the cell type and/or maturity level of cortical vs. thalamic originating axons.

The level of nestin expression in neurons influences growth cone morphology and response to Sema3a
--------------------------------------------------------------------------------------------------

An important question is whether nestin plays a functional role in axons or is simply left over from the mother NPC and no longer plays a role. As a starting point for probing whether nestin still has a function in neurons, we determined whether axons and growth cones were the same or different in neurons with (+) and without (--) nestin (representative images in [Figure 4](#F4){ref-type="fig"}A). We measured axon length, growth cone area, and number of growth cone filopodia (diagram in Supplemental Figure S4F). Nestin levels were not correlated with any variance in axon length ([Figure 4](#F4){ref-type="fig"}E), but interestingly, growth cone area was significantly smaller when nestin was present ([Figure 4](#F4){ref-type="fig"}F). This finding is consistent with previous reports in frog neurons, where the neurons expressing the nestin homolog, tannabin, had smaller blunted growth cones ([@B35]). How growth cone size is regulated and what effect growth cone size has on growth cone functions is unknown, but other molecules that regulate the actin and microtubule cytoskeleton display a similar phenotype. Growth cone size therefore may be representative of the underlying overall cytoskeletal dynamics, where a more stable cytoskeleton leads to larger growth cones, and a more dynamic cytoskeleton leads to smaller growth cones ([@B71]; [@B47]). Others have noted a correlation between axon growth rates and growth cone size; however, our measurements of axon length do not show any significant differences ([@B1]; [@B72])*.*

![Nestin-expressing neurons have smaller growth cones with fewer filopodia and are more sensitive to Sema3a in a cdk5-dependent manner. E16 mouse cortical neurons 1DIV (stage 3) were immunostained against DCX (to confirm neuronal identity), phalloidin (to visualize the growth cones), and nestin. Cells were characterized based on nestin immunoreactivity in the distal axon nestin as Nes(--)---not detected, Nes(+)---nestin-positive. Conditions are untreated (A), 1 nM Sema3a 5 min (B), pretreated with 10 µM Roscovitine 30 min prior to 1 nM Sema3a treatment for 5 min (C), and a Sema3a++ treatment of 2 nM Sema3a for 15 min (D). Insets allow appreciation of the filamentous nature of the nestin immunostaining and proximity to the growth cone. Channel intensity is adjusted equally for nestin and DCX. At low magnification, phalloidin labeling has been adjusted variably to show morphology, but in the insets the phalloidin channel was adjusted in an equal manner. Nestin-expressing neurons are not significantly different by axon length (E), but have significantly smaller axon growth cones (F). Neuron morphology was quantified (30--40 cells per independent experiment). Mean of each experiment and SEM are indicated. Statistical test was a *t* test with *n* = 6 (E) or *n* = 5 (F). (G) Neurons with nestin have fewer filopodia than those without nestin. In cells treated with 1 nM Sema3a for 5 min, the nestin-positive cells had a significant reduction in filopodia in comparison with untreated nestin-positive cells, whereas the nestin-negative cells did not. Conditions have been color coded for ease of comparison. Roscovitine inhibited the decrease in filopodia number after Sema3a treatment. When a high dose (2 nM) and longer treatment (15 min) of Sema3a are used, both nestin-negative and -positive neurons retract filopodia and significantly so, indicating that nestin is not absolutely required for Sema3a-induced filopodial retraction, but increases Sema3a sensitivity. Filopodia number was quantified for 6 (vehicle, Sema3a), 4 (roscovitine + Sema3a), or 3 (Sema3a++) independent experiments. An average of 30--40 cells quantified per experiment is shown. Mean of each experiment and SEM are indicated. Normality was confirmed with the Shapiro--Wilk normality test. Statistical test was one-way ANOVA with Tukey's multiple comparison correction, with *n* = number of experiments. Each condition was compared with every other condition.](mbc-30-1214-g004){#F4}

Because nestin regulates cdk5-dependent processes in muscle cells ([@B100]), we wondered whether nestin could affect cdk5-dependent processes in neurons as well. Sema3a is upstream of cdk5 in neurons ([@B77]; [@B65]), and we thus utilized an in vitro bath application "Sema3a collapse assay" to test this idea. In cultured neurons, phosphorylation of cdk5 substrates and morphological changes in growth cones ([@B23]; [@B69]) start within minutes of Sema3a exposure with the loss of growth cone filopodia, resulting ultimately in a collapsed growth cones with no filopodia. Therefore, before complete growth cone collapse, Sema3a leads to retraction of individual filopodia ([@B23]). Given nestin's role in promoting cdk5 activity at the neuromuscular junction, we hypothesized that growth cone filopodial retraction in response to Sema3a occurred in a nestin-sensitive manner. To quantitatively address this, we counted actin-rich filopodial protrusions of the growth cones ([Figure 4](#F4){ref-type="fig"}G). In untreated cells, filopodia number was inversely correlated to axonal nestin levels ([Figure 4](#F4){ref-type="fig"}G). After a low dose of Sema3a treatment (1 nM for 5 min; [@B69]), nestin-positive cells retracted growth cone filopodia significantly, whereas nestin-negative growth cones were not significantly affected by Sema3a during the 5 minute timeframe (shown in [Figure 4](#F4){ref-type="fig"}B, quantified in [Figure 4](#F4){ref-type="fig"}G). The area of the growth cone was not significantly altered in this short time frame as expected ([@B23]), so we relied on the retraction of filopodia as our most sensitive measurement of Sema3a sensitivity. Because Sema3a is known to act in part through cdk5, we added 10 µM of the cdk inhibitor roscovitine for 30 min before Sema3a application. Roscovitine pretreatment inhibited the decrease in filopodia number after Sema3a treatment ([Figure 4](#F4){ref-type="fig"}, C and G). Roscovitine inhibits cdk5 potently, but it also inhibits some of the mitotic cdks (cdk2 and cdc2), albeit less effectively. Because neurons are postmitotic, they have few to none of the mitotic cdk activities. It is thus likely that the roscovitine inhibition of the Sema3a effect is due to cdk5 inhibition.

Last, nestin is not absolutely required for Sema3a sensitivity, since higher and longer Sema3a stimulation (2 nM for 15 min) resulted in filopodial retraction even in nestin-negative cells ([Figure 4](#F4){ref-type="fig"}, D and G). Together these data demonstrate a strong correlation between axonal nestin expression and growth cone size, and Sema3a-mediated filopodial retraction.

Nestin depletion results in abnormal growth cone morphology and decreased sensitivity to Sema3a
-----------------------------------------------------------------------------------------------

To test for nestin-dependent sensitivity to Sema3a directly, we used nestin siRNAs to deplete nestin protein from neurons and assess growth cone morphology and response to Sema3a. Neurons electroporated with the siNes-pool and GFP (to visualize transfected cells; [Figures 1](#F1){ref-type="fig"}C and [5](#F5){ref-type="fig"}, A and E; Supplemental Figure S1A) were analyzed for differences in morphology. Neurons that received the siNes pool had no variance in axon length ([Figure 5](#F5){ref-type="fig"}C) but had large growth cones ([Figure 5](#F5){ref-type="fig"}D) and more growth cone filopodia ([Figure 5](#F5){ref-type="fig"}F) than siCon, mirroring the effects seen from analysis of endogenous variation of nestin expression ([Figure 4](#F4){ref-type="fig"}). To confirm that this effect was specific to nestin depletion and not an off-target effect, the four siRNAs that make up the siNes-pool were tested individually. Two of them (\#1 and \#17) were effective both for depleting nestin and for increasing growth cone size and filopodial number (Supplemental Figure S4, A--E). More than one distinct siNes thus resulted in the same phenotype as the siNes pool, consistent with specificity of the phenotype to nestin depletion. Consistent with this conclusion, siNes \#4 failed to reduce nestin levels and did not affect growth cone morphology, similarly to siCon (Supplemental Figure S4, A--E).

![Nestin siRNA results in abnormal growth cone morphology and resistance to Sema3a. Representative images of primary E16 mouse cortical neurons that were cotransfected with a plasmid encoding GFP and either control siRNA (siCon) or nestin siRNA (siNes) and cultured for 36 h. GFP booster was used to visualize transfected cells, Tuj1 (βIII-tubulin) was used to confirm neuronal identity and for cell morphology, and phalloidin to visualize growth cones (A, E). The efficiency of nestin knockdown was quantified (B) by counting GFP (transfected) and nestin-positive cells by immunostaining in stage 3 neurons. Approximately one-third of siCon neurons express nestin at 36 h in the axon. Very few transfected neurons showed nestin expression in the axon under siNes conditions. 120-140 cells per condition were counted in *n* = 5 independent experiments. *p* \< 0.001 (paired *t* test). In vehicle-treated conditions (A), siNes treated cells had no significant difference in axon length (C) but resulted in significantly larger growth cones (D). *n* = ∼100 cells (plotted on the graph) were measured for each condition and significance was measured by an unpaired Mann--Whitney rank comparison test. A Shapiro--Wilk normality test indicated that the data were not normal. A *t* test was also performed (to be consistent with other analyses) for the growth cone area data separately with each experimental average, *n* = 4 (each a different color on graphs), and resulted in a significant *p* value of 0.025. siCon- or siNes-transfected neurons were treated for 5 min with 1 nM Sema3a (E). siNes resulted in more filopodia per growth cone, and these filopodia were resistant to Sema3a retraction (F). Approximately one hundred cells in four independent experiments were averaged and *n* = 4 was used for statistical analysis (one-way ANOVA with Sidak correction---only the pairs shown were compared). Normality was confirmed with the Shapiro--Wilk normality test.](mbc-30-1214-g005){#F5}

As expected, siCon-transfected neurons had a significant reduction in filopodia number following 1 nM Sema3a treatment for 5 min. Neurons transfected with the siNes pool and then treated with Sema3a (1 nM 5 min), in contrast, showed no change in filopodia number ([Figure 5](#F5){ref-type="fig"}E), and they were thus insensitive to this dose of Sema3a. These results demonstrate, surprisingly, that nestin increases the sensitivity of axonal growth cones to Sema3a.

DISCUSSION
==========

Neural development requires that axonal growth cones respond to a variety of extracellular guidance cues to change their direction of growth for proper wiring of the nervous system ([@B49]). Importantly, not all growth cones traversing the same environment respond the same way to the same cues at the same time ([@B61]; [@B11]; [@B105]). Even more remarkably, the same growth cone often responds differently to the same axon-guidance cue when encountering it at a different point in time and space ([@B49]). As an axon grows into new brain regions, it must therefore respond not only to new cues, but often differently to the same, previously encountered cue. The molecular mechanisms underlying this variable response to the same cue are poorly understood. We propose that nestin acts as a sensitizer and might provide a gain control mechanism, such that axons lacking nestin are less repelled by Sema3a than axons expressing nestin.

Nestin is highly expressed in NPCs, but expression persists in young neurons
----------------------------------------------------------------------------

We made the surprising discovery that nestin, the most commonly used marker for NPCs, is also found in young neurons. Our conclusion that nestin is in fact expressed in neurons is based on multiple lines of evidence, including multiple antibodies to distinct epitopes, multiple distinct siRNAs to knockdown expression, and peptide blocking of nestin immunostaining.

We find that nestin localizes predominantly to the distal axon and is not found enriched at dendritic tips. This is an intriguing observation, given the importance of neuronal polarity ([@B85]) and of the opposite growth directions of the future axons and apical dendrite in early cortical neurons ([@B106]; [@B105]). In the distal axon, nestin is found in tightly bundled filaments that codistribute with other neuronal intermediate filaments at the wrist region of the growth cone, but individual nestin filaments can also be seen to extend into the central region of the growth cone and even sometimes into the periphery. Nestin is thus well positioned to regulate growth cone dynamics.

A remaining question is whether the nestin protein detected in neurons is a remnant that was translated when the cell was an NPC, or is made from nestin mRNA in neurons. Our ability to knock down nestin with siRNA following dissociation suggests that nestin mRNA is present after dissociation and actively translated in early neurons. Several papers have described nestin mRNA in neurons in developmental, normal adult, and pathological/injury contexts ([@B19]; [@B50]; [@B104]; [@B70]; [@B2]; [@B7]; [@B24]; [@B28],[@B29]). Nestin expression is thus not excluded from neurons. Nestin's presence in subpopulations of adult neurons suggests that some neurons may never lose nestin expression or may regain it later. The best evidence for nestin mRNA in early postmitotic cortical neurons arises from a single cell RNA-seq experiment in which flash tag labeling was used to birthdate newborn cells in the cortex of an E14 mouse embryo in utero, followed by dissociation and single-cell RNA-seq 6--48 h after labeling ([@B86]). This unbiased single-cell approach in vivo revealed that nestin mRNA does persist in some newborn neurons of the embryonic mouse cortex 24--48 h after cell division. This suggests that early neurons continue to make new nestin. We propose that newly made neuronal nestin still plays a functional role. Furthermore, the initial nestin mRNA localization study did detect nestin mRNA in the intermediate zone ([@B20]), where early axons are located.

A role for neuronal nestin in vivo?
-----------------------------------

Little is known about nestin function in the developing brain overall, and existing reports of nestin phenotypes are conflicting. A number of defects have been reported for nestin knockdown in neural stem cells in culture, including increased cell death, but proliferation and differentiation were reportedly normal ([@B25]; [@B39]). Down-regulation of nestin also augmented sensitivity to oxidative stress ([@B76]), implicating nestin in cellular stress pathways. In zebrafish, microcephaly and small eyes were reported after knockdown of nestin expression with morpholinos ([@B16]). Again, NPC cell death was increased. There were also some defects in axon tracts, but it was not clear whether these were a consequence of NPC phenotypes or independently arising in neurons. Another paper used in utero electroporation of shNestin into rat embryos and found fewer migratory neurons ([@B95]). This was reported to be due to cell cycle arrest of NPCs in the G1 phase of the cell cycle. Cell death was not increased. The shNestin phenotype could be rescued with WT nestin ([@B95]). The same year, the first mouse nestin KO papers were published. One paper reported embryonic lethality with severe brain defects due to increased NPC cell death ([@B68]). The reported phenotype thus appeared similar to the zebrafish phenotype and possibly also to the rat shNes phenotype. A second nestin KO paper, in contrast, reported viable and fertile mice showing only mild motor deficits ([@B62]). The motor deficits were traced to defects in myoblasts, resulting in abnormal NMJ formation with impaired AChR clustering. Adult (but not embryonic) neurogenesis was found to be impaired in the viable nestin KO strain by a surprising non--cell autonomous mechanism where nestin-expressing astrocytes regulate Notch signaling in progenitors to maintain stemness ([@B94]). In addition, some behavioral defects were described in the same paper, in particular with respect to long-term memory in an object recognition test ([@B94]). A role for nestin in maintaining NPC pools is thus likely, but data are contradictory and controversial. Furthermore, the mechanism by which nestin might regulate embryonic NPC pools is not known.

A role for nestin in neurons during embryonic development is completely unknown. We provide evidence that nestin modulates responsiveness to Sema3a in cultured cortical neurons. What role could the neuronal nestin play in vivo? At these early developmental time points, Sema3a is important for initial axon positioning and fasciculation ([@B5]; [@B103]). Because Sema3a exists in vivo as a gradient emanating from the ventricular zone and cortical plate, it is conceivable that nestin-mediated Sema3a sensitivity could dictate the position of the axon within the IZ ([@B74]). We were unable to deplete nestin in vivo acutely, because nestin depletion by in utero short hairpin RNA electroporation results in loss of migratory neurons in the cortex. Because nestin expression is much higher in NPCs, the authors conclude that this phenotype is likely due to impaired cell division of NPCs ([@B95]), precluding analysis of nestin function in postmitotic neurons. More detailed analysis of the nestin-positive axons in vivo will be needed to predict more precisely what guidance defects might be found if neuronal nestin expression were disrupted. Given our results, this is something of great interest to do in the future, but a conditional KO might be needed to avoid depleting nestin in NPCs in order to separate any effects of nestin in NPCs from those in early neurons.

Nestin as a novel gain control element in Sema3a signaling
----------------------------------------------------------

Several other molecules have been shown to modulate responsiveness to guidance cues ([@B43]), including coreceptors ([@B21]), lipid raft components ([@B11]), second messengers (such as cAMP/cGMP and calcium; [@B37]; [@B80]; [@B87]), and modification of downstream signaling cascades by ERM ([@B61]), α2-chimaerin ([@B10]; [@B42]), and 14-3-3 proteins ([@B46]; [@B97]). Our results now add the intermediate filament protein nestin to this category of proteins that can variably regulate responsiveness to Sema3a. The previously identified modulators often serve to vary the degree of signaling output to alter the cytoskeleton and adhesive properties of the growth cone ([@B89]; [@B105]). Nestin might similarly modulate cytoskeletal responses to Sema3a, but the molecular mechanism is currently not known. Multiple cytoskeletal proteins are known substrates for cdk5 and act downstream of Sema3a. They are obvious candidates for being nestin effectors in this cascade and mediating the increased Sema3a sensitivity of nestin-expressing neurons. Studies on the role of nestin in cancer cells has demonstrated the importance of nestin for migration/invasion, proliferation, and survival of cancer cells---which are reduced after nestin depletion by altering cell signaling pathways ([@B93]; [@B41]; [@B64]; [@B102]; [@B55]; [@B101]). How nestin promotes higher sensitivity to low doses of Sema3a remains unknown, and future investigation will assess how phosphorylation of cdk5 substrates is affected by the presence or absence of nestin.

One other remaining question is how nestin, which is primarily localized to the distal parts of the axon and to the central domain and/or wrist of the growth cone, affects the stability and dynamics of peripherally localized filopodia. Other examples of proteins initially described as being wrist-localized have been found to affect filopodial morphology, but it is an open question how actin-based structures and microtubule networks coordinate growth cone morphology and axon growth ([@B32]; [@B3]). In fact, intermediate filaments are known to cross-link and interact with these other cytoskeletal elements ([@B14]). Nestin might similarly affect the other structures of the growth cone by structural or regulatory cross-talk. This is currently not known, but is an exciting future direction for further research.

In summary, we have identified nestin intermediate filament protein at the axonal growth cone, where it plays a role in regulating growth cone morphology. In addition, we have identified nestin as a novel downstream effector of Sema3a signaling. Nestin intermediate filament protein could thus play critical regulatory roles in axon guidance responses by serving as a "gain control" element to increase responsiveness of a subset of axons to a common guidance cue.

MATERIALS AND METHODS
=====================

Antibodies
----------

Mouse anti-nestin Rat401: Recognizes the unique C-terminal tail region of nestin ([@B84]). All experiments shown with 2q178 were also repeated with this antibody. Note that this antibody and the other antibodies recognize full-length nestin. 1:200 IF, 1:500 IHC, 1:500 WB. DSHB Cat.\# Rat-401; also rat-401 RRID:AB_2235915'

Mouse anti-nestin 2q178: This clone and RAT401 produce indistinguishable staining patterns. All staining and blotting were done with this antibody unless otherwise noted. 1:200 IF, 1:500 IHC, 1:500 WB. Santa Cruz Biotechnology Cat.\# sc-58813; RRID:AB_784786.

Goat anti-nestin R-20: Raised against peptide in the unique C-terminal tail region of nestin. 1:500 IF, 1:200 IHC. Santa Cruz Biotechnology Cat.\# sc-21249; RRID:AB_2267112.

Chicken anti-nestin: Three peptide-directed antibodies combined with the unique C-terminal tail region of nestin. 1:300 IF, 1:400 IHC, 1:3000 WB. Aves Labs Cat.\# NES RRID:AB_2314882.

Rabbit anti-nestin AB92391: Raised against peptide in the unique C-terminal tail region of nestin. 1:500 IF. Abcam Cat.\# ab92391; RRID:AB_10561437.

Rabbit anti-DCX: 1:1200 IF, IHC, 1:4000 WB. Abcam Cat.\# ab18723; RRID:AB_732011.

Mouse anti-βIII tubulin Tuj1: 1:800 IF. A generous gift from the Deppman Lab, University of Virginia (UVA), A. Frankfurter, UVA Department of Biology. Cat.\# TuJ1 (beta III tubulin); RRID:AB_2315517.

Chicken anti-βIII tubulin: 1:200 IF. Aves Labs Cat.\# TUJ RRID:AB_2313564.

Rat anti α-tubulin: 1:2000 WB. Santa Cruz Biotechnology Cat.\# sc-53030; RRID:AB_2272440.

Rabbit anti-vimentin: 1:100 IF, 1:100 IHC, 1:1000 WB. Bioss Cat.\# bs-0756R; RRID:AB_10855343.

Rat anti-Myc tag 9E1: 1:1000 WB. ChromoTek Cat.\# 9e1-100; RRID:AB_2631398.

Mouse anti-neurofilamentM 2H3: 1:200 IF. DSHB Cat.\# 2H3; RRID:AB_531793.

Mouse anti-αinternexin 2E3: 1:100 IHC. Sigma-Aldrich Cat.\# I0282; RRID:AB_477086.

Rat anti-L1: 1:150 IHC. Millipore Cat.\# MAB5272; RRID:AB_2133200.

Mouse anti-Tag1-4D7 (DSHB): 1:150 IHC. DSHB Cat.\# 4D7; RRID:AB_2315433.

Rabbit anti-calretinin: 1:600 IHC. Millipore (Chemicon) Cat.\# PC254L-100UL; RRID:AB_564321.

Goat anti-Sox2: 1:250 IF. Santa Cruz Biotechnology Cat.\# sc-17320; RRID:AB_2286684.

Rat anti-CTIP2: 1:400 IF. BioLegend Cat.\# 650601; RRID:AB_10896795.

Rabbit anti-SatB2: 1:400 IF. Abcam Cat.\# ab92446; RRID:AB_10563678.

GFP booster nanobody: 1:600 IF. ChromoTek Cat.\# gba488-100; RRID:AB_2631434.

Phalloidin 568: 1:150 Invitrogen.

Neuronal culture
----------------

Primary cultures of cortical neurons were obtained from embryonic day 16 (E16) mouse cortex of either sex as described. The protocol follows institutional animal care and use committee (ACUC) protocols (approved animal protocol \#3422). Cells were plated on poly-[l]{.smallcaps}-lysine coverslips and incubated with DMEM with 10% fetal bovine serum (FBS). After 8 h, the cells were transferred into serum-free medium supplemented with B27 (Invitrogen) and glutamine and cultured for a total of the indicated time periods in vitro (DIV). Cells were plated at ∼100,000 cells per 15-mm coverslip, or at 50,000 in the low-density experiment, or 125,000/coverslip in electroporation experiments. Cortical neurons for culture were harvested at E16 before gliogenesis. Thus nonneuronal glia are rare in these cultures, but occasional nestin/Sox2-­positive, GFAP-negative persisting neural stem cells were found.

Two-dimensional explants were acquired from E16 cortex, but only partially dissociated before plating as described above.

Cells for Sema3a treatment assay were prepared as described above. At 24 or 36 h, cells were treated with mouse Sema3a (R&D Systems) diluted in growth media for 5 min at 1 nM or 15 min at 2 nM as indicated before fixation. In some experiments, cells were pretreated with 10 µM Roscovitine (Cayman Chemical) for 30 min before Sema3a treatment. Time course experiments were fixed at the indicated time points after plating.

Immunofluorescence
------------------

Cells were fixed in 4% paraformaldehyde--PHEM--sucrose (PPS: 60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl~2~ \[PHEM\], 0.12 M sucrose, 4% paraformaldehyde, pH 7.4) for preservation of the cytoskeleton and cellular morphology with prewarmed fixative and fixed at 37°C for 20 min. Thorough permeabilization was required for nestin/intermediate filament visualization in neurons. Coverslips were permeabilized with 0.4% Triton X-200 in 1% BSA/PBS for 20 min for nestin and intermediate filament staining, or 0.2% Triton-X when no intermediate filaments were being immuno­stained, and then blocked for 30 min in 10% BSA, 5% normal donkey serum (NDS) in phosphate-buffered saline (PBS). Primary antibodies were diluted in 1% BSA in PBS, and secondary antibodies in 1% BSA, 0.5% NDS in PBS. Primary antibodies were incubated overnight at 4°C, and secondary antibodies for 90 min at room temperature. Appropriate species-specific Alexa-350-, -488-, -568-, or -647-labeled secondary antibodies raised in donkey (Invitrogen) were used for fluorescent labeling. Phalloidin-568 (Invitrogen) at 1:150 was used to visualize F-actin and DAPI to visualize nuclei. For peptide-blocking negative control experiments, the goat anti-nestin antibody was diluted at 1:500 with the corresponding immunizing peptide (Santa Cruz) at 1:50 and incubated at room temperature for 3 h. The goat anti-nestin antibody for the nonblocked condition was diluted and incubated similarly, but in the absence of peptide. Coverslips were mounted with ProLong Gold (Invitrogen) and imaged with a Zeiss Z1-Observer with a 40× (for population counting) or 63× (for morphology analysis) objective. Images were captured with an Axiocam503 camera using Zen software (Zeiss) and processed identically within experiments. No nonlinear image adjustments were performed.

Histology
---------

Human IPSC--derived cortical organoids (minibrains) or embryonic E16 mouse brain were dissected and placed in 4% PFA and 6% sucrose in PBS at 4°C overnight. Tissue was then cryoprotected by sinking overnight in 30% sucrose. Tissue was imbedded in OCT, and brains were cut by coronal cryosection into 16-µm sections (Zeiss confocal imaging) or 10-µm sections (Abberior superresolution). Sections were mounted directly on slides, permeabilized with 3% NDS + 0.2% Triton X-100 in PBS for 1 h, and blocked with 10% BSA for 30 min. Indicated primary antibodies were diluted in permeabilization buffer overnight at 4°C, and secondary antibodies 2 h at room temperature following thorough washing with PBS. Sections were mounted with Prolong Gold. For peptide-blocking negative control experiments, the goat anti-nestin antibody was diluted at 1:100 with the corresponding immunizing peptide (Santa Cruz) at 1:10 and incubated at room temperature for 3 h. The goat anti-nestin antibody for the nonblocked condition was diluted and incubated similarly, but in the absence of peptide. The antibody was then used as described above. Of note, the anti-Tag1 IgM antibody has a cross-reaction with mouse immunoglobulin G (IgG) secondary antibodies, so staining with mouse IgG and mouse IgM antibodies was done sequentially. Confocal imaging of cryosections was carried out on an inverted Zeiss LSM880 confocal microscope using a 63× objective. Superresolution STED imaging utilized an Abberior STED confocal with 100× objective at the Keck Microscopy Center (UVA). A donkey anti--goat-488 (Invitrogen) secondary antibody was imaged using a 595-nm extinction laser.

Neuron nucleofection
--------------------

After cells were dissociated from cortex, but before plating, they were electroporated by Amaxa 4d nucleofection according to the manufacturer's protocols. Eight hundred thousand cells were electroporated in small-volume (20-µl) cuvettes using P3 primary cell solution and EM-100, CL-133, and CU-100 programs variably between experiments. All three of these programs worked similarly in our hands. GFP plasmid (pCMV-GFP-Clonetech; 0.1µg) was used as a transfection marker, together with 100 nM siRNA (siCON-SCBT sc-37007, siNes smart-pool Dharmacon siGenome M-057300-01-0010, consisting of four individual siRNAs \[D-057300 -01,-03,-04, and -17\] with target sequences siRNA \#1- AAAGGUGGAUCCAGGUUA, siRNA \#3 D-AGACAAGACUCAUGAGUC, siRNA \#4 CAGCAGGCAUUUAGACUUC, siRNA \#17 GCGACAACCUUGCCGAAGA). All four target the region in the mRNA corresponding to the unique C-terminal tail of nestin protein, which is unlike other intermediate filaments.

Molecular biology
-----------------

Circular mouse nestin cDNA was obtained as a gift from Bruce Lahn (University of Chicago). Briefly, PCR was used to generate *Eco*R1 and *Hin*dII sites on the 5′ or 3″ end, respectively, of full-length mouse nestin. Both the insert and vector were treated with *Eco*R1 and *Hin*dII. The cut insert was ligated into pCDNA3.1 Myc-His(+) B.

Cell culture and transfection
-----------------------------

HEK293 cells were maintained in DMEM + 10% FBS, and all transfections were conducted using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. mNestin-myc and respective control or nestin siRNAs were transfected simultaneously according to the recommended instructions.

Western blot
------------

Cells were washed with ice-cold PBS and lysed directly on the plate (6 cm) into lysis buffer (400 µl; 50 mM Tris HCl, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM dithiothreitol \[DTT\], 1 mM phenylmethylsulfonyl fluoride \[PMSF\], 1× HALT protease/phosphatase inhibitor cocktail). After rotisserie of lysates at 4°C for 30 min, lysates were cleared by centrifugation at 21,000 × *g* for 15 min at 4°C. Supernatants were diluted with 5× Laemmli buffer and equivalent amounts were run on a 4--20% polyacrylamide gel. After transfer onto nitrocellulose with the BioRad Transblot, the membrane was blocked with Licor TBS blocking buffer for 1 h at room temperature. Primary and secondary antibodies were diluted in 50% blocking buffer, 50% PBS, 0.1% Tween-20. Peptide blockage was performed on diluted primaries in blocking buffer for 8 h at room temperature with a 10× excess of peptide to antibody ratio before incubation with blots. Primary antibodies were incubated overnight at 4°C, followed by near-infrared secondary antibodies for 1 h at room temperature. Blots were imaged with a Licor Odyssey CLx imager.

Image analysis
--------------

ImageJ was used for all image analysis.

Neuron morphology and nestin expression analysis
------------------------------------------------

Neuron staging was performed according to the Banker neuron staging method, and neurites were designated as axons if they were 2× longer than the next longest neurite (dendrites). Nestin positiveness in the axons of neurons was assessed by outlining the distal region of the axon and measuring the maximum nestin immuno­staining in the region. If this value was at least 1.5× average background, then a cell was considered positive for nestin. In siRNA experiments, only green GFP+ (transfection indicator) cells were imaged and counted for both morphology and nestin siRNA efficiency analysis. All counts were confirmed by blind analysis. How morphology measurements were made is depicted in Supplemental Figure S4F.

Filopodial protrusions were counted using the phalloidin channel, and any actin-rich protrusion from the growth cone was counted.

Axon length was the length of the axon from the cell body to the growth cone tip.

Growth cone area and perimeter were assessed by measuring traced outlines of the growth cone, not counting the filopodial protrusions, and extending down to the point where the splayed growth cone microtubules consolidated into bundles in the axon shaft.

Mouse neural stem cell marker expression was assessed by manually counting DCX-, nestin-, and DAPI-stained differentiated neural stem cells for immunopositivity above background levels in any part of the cells.

Human IPSC nestin and βIII tubulin colocalization was assessed per image using the ImageJ colocalization plug-in.

Mouse neural stem cell culture
------------------------------

Embryonic (E16) cortical neural stem cells were prepared as described by [@B66] and grown as neurospheres for at least three passages to ensure purity before use for dissociated and differentiating cell experiments. For these experiments, neurospheres were dissociated using a stem cell chemical dissociation kit, plated in poly-[l]{.smallcaps}-lysine--coated coverslips for 1 d, and fixed and immuno­stained as described. For 4DIV, proliferative medium was replaced with media lacking EGF and FGF growth factors until 4 DIV, fixed, and processed for immunostaining as described.

Neural differentiation of human induced pluripotent stem cells
--------------------------------------------------------------

Human induced pluripotent stem cells from neurotypic control 9319 were generated by Kristen Brennand in the laboratory of Fred Gage (Salk Institute). NPCs were generated through an embryoid body protocol as described by [@B9]. For neuronal differentiation, we plated 75,000 control NPCs on each poly-ornithine- and laminin-coated 18-mm glass coverslip. After 24 h, cells were switched to neuronal differentiation media consisting of DMEM F12 + Glutamax and supplemented with N2 and B27 with retinoic acid and 20 ng/ml BDNF, 20 ng/ml GDNF, 400 µM cyclic AMP, and 200 nM ascorbic acid. Half of the medium was replaced with fresh medium every 3 d. Neurons were fixed with 4% formaldehyde with 4% sucrose on the days indicated and used for subsequent immunofluorescence analysis.

Generation of cortical organoids
--------------------------------

Human fibroblasts from neurotypic control 7545 were obtained from the Coriell Institute and reprogrammed into induced pluripotent stem cells by the laboratory of Mike McConnell (UVA) using a CytoTune Reprogramming Kit (Life Technologies) and maintained in Essential 8 media (Life Technologies). Cortical organoids were grown using a low-attachment protocol. Briefly, we used dispase to detach hIPSC colonies from matrigel dishes. These colonies were placed in ES/DMEM medium (GlobalStem) supplemented with 20% Knockout Serum Replacement (Life Technologies) and treated with 5 mM Dorsomorphin and 10 mM SB-431542 for the first 5 d. The ROCK inhibitor Y-27632 (10 mm) was added for the first 48 h. From day 6 to day 24, spheroids were fed with neuronal medium consisting of Neurobasal A with B27 without vitamin A, GlutaMax, and penicillin/streptomycin (Life Technologies) and supplemented with 20 ng/ml EGF and FGF2 (Peprotech). From day 25 to day 42, the growth factors were replaced with 20 ng/ml BDNF and NT3 (Peprotech). From day 43 onward, BDNF and NT3 were removed and organoids were grown solely in neuronal medium.

Statistical analysis
--------------------

Human IPSC nestin and β3 tubulin colocalization was performed using Sigma Plot 13.0. All other statistical analysis was carried out using Prism software. The data sets were first evaluated as parametric versus nonparametric using the Shapiro--Wilk normality test. The corresponding one-way analysis of variance (ANOVA) test was used when there were multiple comparisons, and the *t* test was used when only two conditions were compared. This is specified in the figure legends. Significance is denoted throughout with the following abbreviations: n.s. is not significant, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\* *p* \< 0.001, \*\*\*\**p* \< 0.0001.
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